本頁面由Tiger Trade Technology Pte. Ltd.提供服務

燃石醫學

18.73
+0.17500.94%
成交量:9,188.00
成交額:16.60萬
市值:2.02億
市盈率:-25.52
高:18.73
開:18.19
低:18.18
收:18.55
52周最高:41.72
52周最低:2.18
股本:1,076.66萬
流通股本:483.30萬
量比:1.53
換手率:0.19%
股息:- -
股息率:- -
每股收益(TTM):-0.7337
每股收益(LYR):-0.7337
淨資產收益率:-9.92%
總資產收益率:-4.02%
市淨率:2.59
市盈率(LYR):-25.52

資料載入中...

2025/04/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/26

SEC問詢函

Form CORRESP - Correspondence
2024/11/26

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/04/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/30

SEC問詢函

Form CORRESP - Correspondence
2023/08/11

SEC問詢函

Form CORRESP - Correspondence
2023/04/20

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/09/28

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/20

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/12

SEC問詢函

CORRESP [Cover] - Correspondence